LCTX

AMEXStock

Lineage Cell Therapeutics, Inc.

$1.61+0.03 (+1.90%)

52-Week Range

$0.39

$1.96

Key Stats

Market Cap

370.8M

P/E Ratio

—

Dividend Yield

—

Beta

1.74

Volume

1.2M

Avg Volume

1.3M

Performance

-7.06%

-8.14%

+17.04%

YTD

-3.66%

+203.85%

+17.04%

-34.98%

Price Chart

ETF Exposure

LCTX is held by 10 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IBB	iShares Biotechnology ETF	0.03%	1,588,794	$2.7M	$8.50B	0.44%
VALT	ETFMG Sit Ultra Short ETF	0.01%	307,593	$415K	$75.4M	0.30%
SILX	ETFMG Prime 2x Daily Junior Silver Miners ETF	0.01%	307,593	$428K	$5.5M	0.97%
VXF	Vanguard Extended Market ETF	0.00%	2,511,617	$3.7M	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	273	$547	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	9,749	$20K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	47	$94	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	5,550,504	$8.2M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	29,194	$59K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	2,517	$5K	$1.29B	0.17%

About LCTX ETF Exposure

Lineage Cell Therapeutics, Inc. (LCTX) is held by 10 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 370.8M, LCTX is a widely held institutional stock. The stock currently trades at $1.61. Investors can gain exposure to LCTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LCTX, sorted by portfolio weight.